Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy..
Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.
J Cardiothorac Vasc Anesth. 2024 Aug;38(8):1689-1698. doi: 10.1053/j.jvca.2024.04.029. Epub 2024 Apr 24.
Previous studies in other settings suggested that urine output (UO) might affect NephroCheck predictive value. We investigated the correlation between NephroCheck and UO in cardiac surgery patients.
Post hoc analysis of a multicenter study.
University hospital.
Patients who underwent cardiac surgery using cardiopulmonary bypass (CPB) and crystalloid cardioplegia.
All patients underwent NephroCheck testing 4 hours after CPB discontinuation. The primary outcome was the correlation between UO, NephroCheck results, and acute kidney injury (AKI, defined according to Kidney Disease: Improving Global Outcomes). Of 354 patients, 337 were included. Median NephroCheck values were 0.06 (ng/mL)/1,000) for the overall population and 0.15 (ng/mL)/1,000) for patients with moderate to severe AKI. NephroCheck showed a significant inverse correlation with UO (ρ = -0.17; p = 0.002) at the time of measurement. The area under the receiver characteristic curve (AUROC) for NephroCheck was 0.60 (95% confidence interval [CI], 0.54-0.65), whereas for serum creatinine was 0.82 (95% CI, 0.78-0.86; p < 0.001). When limiting the analysis to the prediction of moderate to severe AKI, NephroCheck had a AUROC of 0.82 (95% CI, 0.77 to 0.86; p<0.0001), while creatinine an AUROC of 0.83 (95% CI, 0.79-0.87; p = 0.001).
NephroCheck measured 4 hours after the discontinuation from the CPB predicts moderate to severe AKI. However, a lower threshold may be necessary in patients undergoing cardiac surgery with CPB. Creatinine measured at the same time of the test remains a reliable marker of subsequent development of renal failure.
先前在其他环境中的研究表明,尿量(UO)可能会影响 NephroCheck 的预测价值。我们研究了心脏手术患者的 NephroCheck 与 UO 之间的相关性。
多中心研究的事后分析。
大学医院。
接受体外循环(CPB)和晶体心脏停搏的心脏手术患者。
所有患者在 CPB 停止后 4 小时接受 NephroCheck 检测。主要结果是 UO、NephroCheck 结果与急性肾损伤(AKI,根据肾脏病:改善全球结果定义)之间的相关性。在 354 例患者中,有 337 例患者被纳入研究。总体人群的 NephroCheck 值中位数为 0.06(ng/mL)/1000),中度至重度 AKI 患者的 NephroCheck 值中位数为 0.15(ng/mL)/1000)。NephroCheck 与 UO 呈显著负相关(ρ=-0.17;p=0.002)。NephroCheck 的接收者特征曲线下面积(AUROC)为 0.60(95%置信区间[CI],0.54-0.65),而血清肌酐为 0.82(95%CI,0.78-0.86;p<0.001)。当将分析仅限于预测中重度 AKI 时,NephroCheck 的 AUROC 为 0.82(95%CI,0.77-0.86;p<0.0001),而肌酐的 AUROC 为 0.83(95%CI,0.79-0.87;p=0.001)。
CPB 停止后 4 小时测量的 NephroCheck 可预测中重度 AKI。然而,在接受 CPB 心脏手术的患者中,可能需要更低的阈值。在同一时间测试时测量的肌酐仍然是随后发生肾衰竭的可靠标志物。